13 research outputs found
Comparison of laboratory test results in cases and controls.
<p>Comparison of laboratory test results in cases and controls.</p
Comparison of demographic and epidemiological characteristics in cases and controls.
<p>Comparison of demographic and epidemiological characteristics in cases and controls.</p
Accuracy of diagnostic predictors for IPD.
<p>Abbreviations: NP, nasopharyngeal; Sp, <i>Streptococcus pneumoniae</i>.</p
Correlation analysis between GDF-15 and FGF-21.
<p>serum levels in samples from all patient groups taken as a whole (A), group 1(B), group 2 (C) and group 3(D).</p
Correlation analysis between GDF-15 and FGF-21 protein levels.
<p>in the conditioned medium of C2C12 cells treated with respiratory chain inhibitors.</p
Effects of experimentally induced mitochondrial dysfunction on GDF-15 mRNA expression and GDF15 protein release in muscle cells.
<p>GDF15 mRNA and FGF21 mRNA levels in C2C12 myotubes (A) or LHCN myotubes (B), and correlation between GDF-15 mRNA levels and FGF21 mRNA levels (C) in the experimental settings in C2C12 cells (up) and LHCN cells (down). GDF-15 protein concentrations in C2C12 cell culture medium (D). Bars are means ±S.E.M. from 4–6 independent experiments. *p <0.05, **p <0.01, ***p <0.001, relative to untreated controls. <sup>#</sup> p <0.05, relative to corresponding condition non-treated with Trolox. R and P values are shown in the correlation panel C.</p
Serum concentration of GDF-15 and FGF-21 in patients and controls.
<p>Serum concentration of GDF-15 and FGF-21 in patients and controls.</p
Receiving Operating Curve.
<p>analysis for GDF-15 and FGF-21 considering patients in groups 1, 2 and 3 together (A) or patients group 1(B), group 2 (C) and group 3(D) separately.</p
Correlation analysis between GDF-15 and FGF-21.
<p>serum levels in samples from all patient groups taken as a whole (A), group 1(B), group 2 (C) and group 3(D).</p